1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6F897CA2AE9510C2985257D2C00574BDD
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-medical-science-liaison-management-performance-measurement-budget-and-challenges-lessons-learned?opendocument
18
19opendocument
2034.236.145.124
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




» Products & Services » » Medical Affairs » Medical Science Liaison

Medical Science Liaison Management: Performance Measurement, Budget and Challenges/Lessons Learned

ID: 5320


Features:

19 Info Graphics

15 Data Graphics

150+ Metrics


Pages/Slides: 42


Published: 2014


Delivery Format: Online PDF Document


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from "Medical Science Liaison Management: Performance Measurement, Budget and Challenges/Lessons Learned"


STUDY OVERVIEW

The role of Medical Science Liaisons (MSL) has continued to steadily grow within the healthcare industry. Consequently, Medical Affairs leaders must now, more than ever, re-assess their MSL management practices to be successful in this competitive environment. The study captures critical insights regarding MSL team performance measurement, budget allocations and challenges/lessons learned.

This research presents 2014 data versus data from 2011, and examines the growing roles and responsibilities of Medical Science Liaisons within leading healthcare organizations. Medical Affairs leaders can use this study as a benchmark for future strategic and resource planning and best-practice implementation for the medical science liaison function.

KEY TOPICS

  • Value Associated with MSL and Measuring Effectiveness
  • Budget Allocated to MSL
  • Challenges & Lessons Learned

KEY METRICS
  • Professional background of benchmark class participants
  • Role within Medical Affairs of benchmark class participants
  • Number of approved products
  • Value associated with MSL responsibilities
  • Other valued MSL responsibility & activity areas
  • Effectiveness of quantitative metrics
  • Effectiveness of qualitative metrics
  • Optimal re-allocation of time spent on MSL activities
  • Activities where MSLs should spend time
  • Annual budget for MSL function in ($M)
  • Breakup of MSL budget
  • Funding source for MSLs
  • Factors affecting annual MSL budget
  • Top MSL deployment challenges
  • Top challenges for MSLs
  • Top lessons learned
  • Important lessons to strengthen relationships and market position

METHODOLOGY

Best Practices, LLC engaged 19 leaders at 15 top pharmaceutical companies through a benchmarking survey instrument.  All participants share leadership and oversight of  Medical Science Liaison (MSL) groups at their healthcare organizations. 

Industries Profiled:
Pharmaceutical; Biotech; Manufacturing; Medical Device; Consumer Products; Diagnostic; Chemical; Health Care; Biopharmaceutical; Clinical Research; Laboratories


Companies Profiled:
Abbvie; AstraZeneca Pharmaceuticals; Biogen; BARD; Baxter International; Bayer Healthcare; Covidien; Genentech; Gilead Sciences; Kadmon Pharmaceuticals; Medtronic; Sanofi; Shire; ViiV Healthcare; Jazz Pharmaceuticals


If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.